|
Name |
Viridicatol
|
Molecular Formula | C15H11NO3 | |
IUPAC Name* |
3-hydroxy-4-(3-hydroxyphenyl)-1H-quinolin-2-one
|
|
SMILES |
C1=CC=C2C(=C1)C(=C(C(=O)N2)O)C3=CC(=CC=C3)O
|
|
InChI |
InChI=1S/C15H11NO3/c17-10-5-3-4-9(8-10)13-11-6-1-2-7-12(11)16-15(19)14(13)18/h1-8,17-18H,(H,16,19)
|
|
InChIKey |
QIJIOTTYIGBOQA-UHFFFAOYSA-N
|
|
Synonyms |
Viridicatol; 14484-44-7; 3-hydroxy-4-(3-hydroxyphenyl)-1H-quinolin-2-one; 2(1H)-Quinolinone, 3-hydroxy-4-(3-hydroxyphenyl)-; 45P12JNE0L; Carbostyril, 3-hydroxy-4-(m-hydroxyphenyl)-; UNII-45P12JNE0L; 3-Hydroxy-4-(3-hydroxyphenyl)-2(1H)-quinolinone; 3-hydroxy-4-(3-hydroxyphenyl)quinolin-2(1H)-one; MEGxm0_000057; ACon0_001482; DTXSID60893995; ZINC5117508; NSC794085; NSC-794085; 4-(3-Hydroxyphenyl)-2,3-quinolinediol #; HY-116474; CS-0065593; F76730; 3-hydroxy-4-(3-hydroxyphenyl) quinolin-2(1h)-one; Q27258853; 3-hydroxy-4-(3-hydroxyphenyl)-1,2-dihydroquinolin-2-one; NCGC00380299-01!3-hydroxy-4-(3-hydroxyphenyl)-1H-quinolin-2-one
|
|
CAS | 14484-44-7 | |
PubChem CID | 115033 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 253.25 | ALogp: | 2.0 |
HBD: | 3 | HBA: | 3 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 69.6 | Aromatic Rings: | 3 |
Heavy Atoms: | 19 | QED Weighted: | 0.622 |
Caco-2 Permeability: | -5.042 | MDCK Permeability: | 0.00001090 |
Pgp-inhibitor: | 0.005 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.023 | 20% Bioavailability (F20%): | 0.821 |
30% Bioavailability (F30%): | 0.305 |
Blood-Brain-Barrier Penetration (BBB): | 0.096 | Plasma Protein Binding (PPB): | 97.25% |
Volume Distribution (VD): | 0.355 | Fu: | 1.45% |
CYP1A2-inhibitor: | 0.969 | CYP1A2-substrate: | 0.121 |
CYP2C19-inhibitor: | 0.338 | CYP2C19-substrate: | 0.055 |
CYP2C9-inhibitor: | 0.421 | CYP2C9-substrate: | 0.792 |
CYP2D6-inhibitor: | 0.539 | CYP2D6-substrate: | 0.453 |
CYP3A4-inhibitor: | 0.499 | CYP3A4-substrate: | 0.14 |
Clearance (CL): | 5.596 | Half-life (T1/2): | 0.852 |
hERG Blockers: | 0.047 | Human Hepatotoxicity (H-HT): | 0.09 |
Drug-inuced Liver Injury (DILI): | 0.973 | AMES Toxicity: | 0.277 |
Rat Oral Acute Toxicity: | 0.114 | Maximum Recommended Daily Dose: | 0.023 |
Skin Sensitization: | 0.419 | Carcinogencity: | 0.22 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.531 |
Respiratory Toxicity: | 0.741 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003571 | 0.982 | D09LDR | 0.370 | ||||
ENC005446 | 0.762 | D02TJS | 0.359 | ||||
ENC005445 | 0.586 | D0QV5T | 0.357 | ||||
ENC001109 | 0.535 | D0P3JU | 0.349 | ||||
ENC003390 | 0.500 | D0J6WW | 0.345 | ||||
ENC002926 | 0.443 | D04BNP | 0.345 | ||||
ENC002154 | 0.432 | D0R2OA | 0.341 | ||||
ENC002323 | 0.420 | D0T5WK | 0.341 | ||||
ENC003516 | 0.416 | D06TJJ | 0.340 | ||||
ENC004650 | 0.415 | D07JVL | 0.337 |